ADC Therapeutics SA News, ADC Therapeutics SA Quote, ADCT Quote

ADC Therapeutics SA (NY:ADCT) Delayed: 4.72 -0.04 (0.84%)

Prev. Close

$4.76

Open

$4.76

52 Wk High

$12.76

52 Wk Low

$5.18

Day High

$4.92

Day Low

$4.60

P/E

6.05

EPS

$0.78

Volume

646,030

Friends, Peers and Foes (?): SOBI (more...)

Apr 16, 2024 04:17 PM Form PRE 14A ADC Therapeutics SA For: Jun 13
Apr 9, 2024 04:08 PM Form 8-K ADC Therapeutics SA For: Apr 09
Apr 4, 2024 07:00 AM ADC Therapeutics SA (ADCT) Announces Updates on LOTIS-7 Trial of ZYNLONTA
Apr 4, 2024 07:00 AM ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Apr 3, 2024 07:00 AM ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024
Apr 1, 2024 04:05 PM ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Mar 28, 2024 06:21 AM Guggenheim Starts ADC Therapeutics (ADCT) at Buy
Mar 15, 2024 04:15 PM Form 424B3 ADC Therapeutics SA
Mar 15, 2024 04:14 PM Form 424B3 ADC Therapeutics SA
Mar 15, 2024 06:32 AM Form EFFECT ADC Therapeutics SA

Entities mentioned with ADCT